Phase II Trial of VELCADE (Bortezomib) for Steroid Refractory Acute GVHD.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Bortezomib (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Dec 2016 Last checked against ClinicalTrials.gov record.
- 08 Jun 2011 Primary endpoint added according to ClinicalTrials.gov.
- 08 Jun 2011 Additional lead trial investigator (John Wagner) added as reported by ClinicalTrials.gov.